Home >> Tag Archives: Seattle Genetics

Tag Archives: Seattle Genetics

FDA expands use of Adcetris

January 2019—The FDA expanded the approved use of Adcetris (brentuximab vedotin) injection in combination with chemotherapy for adult patients with certain types of peripheral T-cell lymphoma. This is the first FDA approval for the treatment of newly diagnosed PTCL.

Read More »
CAP TODAY
X